Case Control Study of Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Toxicity
Interventions
OTHER

Pharmacogenomic whole blood sampling

10 mL, whole blood, one sample on Visit 2

Trial Locations (19)

Unknown

Jacksonville

Jupiter

Idaho Falls

Richmond

Córdoba

Québec

Sainte-Foy

Santiago

Havírov-Šumbark

Oulu

Nuremberg

Riga

Groningen

Gdansk

Moscow

Saratov

Žilina

Johannesburg

Glasgow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT00890448 - Case Control Study of Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate | Biotech Hunter | Biotech Hunter